2010 Fiscal Year Final Research Report
New therapeutic approach for glaucoma via drug-mediated bleb regulation
Project/Area Number |
20390449
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Ophthalmology
|
Research Institution | Kumamoto University |
Principal Investigator |
TANIHARA Hidenobu Kumamoto University, 大学院・生命科学研究部, 教授 (60217148)
|
Co-Investigator(Kenkyū-buntansha) |
INATANI Masaru 熊本大学, 医学部附属病院, 講師 (40335245)
KAWAJI Takahiro 熊本大学, 医学部附属病院, 講師 (30423677)
|
Project Period (FY) |
2008 – 2010
|
Keywords | 眼薬理学 / 創傷治癒 |
Research Abstract |
We identified risk factors for surgical failure of trabeculectomy, a major surgery for glaucoma patients. In open-glaucoma patients, previous cataract surgery is a significant risk factor for the surgical failure while previous cataract surgery and granulomatous uveitis-type are risk factors in uveitic glaucoma patients. An anti-VEGF drug, bevacizumab, reduces surgical complications, and improves the short-term surgical success of trabeculectomy.
|
Research Products
(27 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Trabeculectomy with mitomyci C for open-angle glaucoma in phakic eyes vs. pseudophakic eyes after phacoemulsification.2010
Author(s)
Takihara Y, Inatani M, Seto T, Iwao K, Iwao M, Inoue T, Kasaoka N, Murakami A, Futa R, Tanihara H
Organizer
The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) Convention Center
Place of Presentation
Fort Lauderdale, Florida, USA
Year and Date
20100502-20100506
-
-
-
-
-
-
-
-
-
-
-
-
-